Home

C4 Therapeutics, Inc. - Common Stock (CCCC)

3.5700
+0.00 (0.00%)
NASDAQ · Last Trade: Sep 16th, 5:09 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Why C4 Therapeutics Stock Crushed the Market on Mondayfool.com
A major recommendation change lit a big fire under the biotech as the trading week kicked off.
Via The Motley Fool · September 15, 2025
Here are the top movers in Monday's session.chartmill.com
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · September 15, 2025
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · September 15, 2025
Which stocks are moving on Monday?chartmill.com
Looking for insights into the US markets in the middle of the day on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · September 15, 2025
Key Takeaways From C4 Therapeutics Analyst Ratingsbenzinga.com
Via Benzinga · May 9, 2024
Breaking Down C4 Therapeutics: 4 Analysts Share Their Viewsbenzinga.com
Via Benzinga · February 26, 2024
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · August 7, 2025
CCCC Revenue Drops 46%fool.com
Via The Motley Fool · August 7, 2025
Which stocks are moving before the opening bell on Thursday?chartmill.com
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via Chartmill · April 10, 2025
AT&T To Rally More Than 33%? Here Are 10 Top Analyst Forecasts For Thursdaybenzinga.com
Via Benzinga · December 19, 2024
Analyst Expectations For C4 Therapeutics's Futurebenzinga.com
Via Benzinga · January 29, 2024
Methanex, Merck And Other Big Stocks Moving Lower In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · September 9, 2024
Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · September 9, 2024
CCCC Stock Earnings: C4 Therapeutics Beats EPS, Beats Revenue for Q2 2024investorplace.com
CCCC stock results show that C4 Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 1, 2024
CCCC Stock Earnings: C4 Therapeutics Misses EPS, Misses Revenue for Q1 2024investorplace.com
CCCC stock results show that C4 Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 8, 2024
Capital One Financial To Acquire Discover, Joins SSR Mining And Other Big Stocks Moving Lower In Tuesday's Pre-Market Sessionbenzinga.com
U.S. stock futures were lower this morning, with the Dow futures trading lower by around 50 points on Tuesday.
Via Benzinga · February 20, 2024
7 Exciting Stocks Poised for Explosive Growth in Key Sectorsinvestorplace.com
These stocks to buy for growth already have a strong growth story. If they reach their potential investors could see some dynamic returns.
Via InvestorPlace · January 22, 2024
What's Going On With C4 Therapeutics Stock?benzinga.com
C4 Therapeutics, Inc. (NASDAQ: CCCC) shares are trading higher Friday, and the stock has gained more than 350% over the past five days.
Via Benzinga · December 15, 2023
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yetbenzinga.com
A look at five stocks that saw increased interest from Benzinga readers during the week.
Via Benzinga · December 15, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · December 15, 2023
Dow Jumps Over 200 Points; Federal Reserve Holds Interest Rates Steadybenzinga.com
U.S. stocks traded higher toward the end of trading, after the Federal Reserve announced its policy decision on Wednesday. The Dow traded up 0.58% to 36,789.77 while the NASDAQ rose 0.63% to 14,624.74. The S&P 500 also rose, gaining, 0.62% to 4,672.48.
Via Benzinga · December 13, 2023
Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Sessionbenzinga.com
Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial guidance. The company said it now sees revenue of $690 million to $700 million, versus previous forecast of $670 million to $700 million.
Via Benzinga · December 13, 2023
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · December 13, 2023
Crude Oil Gains 1.5%; Blackboxstocks Shares Plummetbenzinga.com
U.S. stocks traded higher midway through trading, following the release of PPI data on Wednesday. The Dow traded up 0.06% to 36,598.24 while the NASDAQ rose 0.23% to 14,566.43. The S&P 500 also rose, gaining, 0.20% to 4,653.07.
Via Benzinga · December 13, 2023
US Stocks Mixed; Producer Prices Unchanged For Novemberbenzinga.com
U.S. stocks traded mixed this morning, following the release of PPI data on Wednesday. Following the market opening Wednesday, the Dow traded down 0.05% to 36,561.18 while the NASDAQ rose 0.42% to 14,594.61. The S&P 500 also rose, gaining, 0.14% to 4,650.04.
Via Benzinga · December 13, 2023